Last reviewed · How we verify
Multi-strain probiotics
Multi-strain probiotics restore and balance the gut microbiota to promote intestinal health and immune function.
Multi-strain probiotics restore and balance the gut microbiota to promote intestinal health and immune function. Used for Gastrointestinal disorders and microbiota dysbiosis.
At a glance
| Generic name | Multi-strain probiotics |
|---|---|
| Sponsor | Seoul National University Hospital |
| Drug class | Probiotic |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology |
| Phase | Phase 3 |
Mechanism of action
Probiotics are live beneficial bacteria that colonize the gastrointestinal tract, competing with pathogenic organisms, producing short-chain fatty acids, and strengthening the intestinal barrier. They modulate the immune system through interactions with gut-associated lymphoid tissue and can reduce systemic inflammation. Multiple strains provide complementary effects on different aspects of microbiota composition and function.
Approved indications
- Gastrointestinal disorders and microbiota dysbiosis
Common side effects
- Gastrointestinal bloating or gas
- Mild abdominal discomfort
Key clinical trials
- Efficacy of Symprove Probiotics in Coeliac Disease (NA)
- Prospective Study to Determine the Factors Influencing Infant Colic (NA)
- Effects of Probiotics on Gut Microbiota, Endocannabinoid and Immune Activation and Symptoms of Fatigue in Dancers (NA)
- Effects of a 5-Week Probiotic Supplementation Intervention on Markers of Delayed Onset Muscle Soreness (NA)
- Impact of a Probiotic Supplementation With Lifestyle Modification on Liver Steatosis, Fibrosis, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (NA)
- Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer (PHASE3)
- Evaluation of the Acceptability of a Multi-strain Probiotic Supplement (Smile Probio 45B) in Healthy Adults (NA)
- Probiotics for Women (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Multi-strain probiotics CI brief — competitive landscape report
- Multi-strain probiotics updates RSS · CI watch RSS
- Seoul National University Hospital portfolio CI